Brownian dynamics simulations of a wild type and mutants of bovine pancreatic trypsin inhibitors were performed using the program brownian. The results of the simulations were consistent with experimentally determined stabilities of these proteins, and the computational times of the simulations were much less than those of molecular dynamics simulations. These results indicate that Brownian dynamics simulations can be useful for investigating structural features of proteins that have some mutants, such as drug-metabolizing enzymes.
In computer-aided drug design (CADD) studies, molecular simulation techniques play important roles along with chemoinformatics and bioinformatics methods. In particular, they are effective in investigating structural features of biopolymers in structure-based drug design (SBDD). Some computational chemistry methods such as molecular dynamics (MD) and Monte Carlo methods are used for molecular simulations. Brownian dynamics (BD) is one of them. Although the treatment of solvent molecules is one of the most important difficulties in molecular simulations, implicit solvent models using the viscosity of the solvent and random forces are adopted in BD without explicit treatments of solvents. Using these models, BD can be performed at a low cost in terms of computational resources, and BD has been used for a wide variety of chemical or biological research, such as protein folding studies 1) and investigations of electron transfer systems. 2) Recently, a few program packages were developed for BD simulations, e.g., University of Houston Brownian Dynamics (UHBD), 3) software developed by Ando et al., 4) and brownian. 5, 6) The program package brownian was developed by our team. It is user-friendly not only for specialists in BD calculations but also for beginners, because it can be used in a similar manner as the program Assisted Model Building with Energy Refinement (AMBER), 7) which is one of the most widely used MD programs. The LEaP module of AMBER can be used to generate topology and coordinate files for brownian, and antechamber software 8) can be used without modifications for simulations of nonpeptidic molecules, such as coenzymes and drugs. In this study, computational accuracies of brownian were investigated by simulations of a wild type and mutants of bovine pancreatic trypsin inhibitors (BPTIs).
BPTI is the peptidic trypsin inhibitor originating from the bovine pancreas. Recently, the experimentally measured stabilities of many mutants of BPTI were reported, 9, 10) suggesting that one of the three disulfide bonds, Cys5-Cys55, plays an important role in the structural stability of BPTI.
11) When the disulfide bond was preserved, BPTI structures were not broken even when all other cysteine residues were mutated to alanine. On the other hand, some studies reported that mutations of residues other than cysteines lowered the stabilities of proteins. 9, 12) This suggests that BPTI is a good example of biopolymers that are highly influenced by mutations. Thus, molecular simulations of mutants of BPTI play significant roles not only in the investigations of structural features of BPTI, but also in the evaluations of structural bioinformatics methods applied to mutants. Because investigating polymorphisms of biopolymers, such as metabolic enzymes, are crucial for drug design trials, 13) computational predictions of three-dimensional (3D) structures of mutant proteins are expected to contribute to drug design and development that considers individual differences, i.e., personalized medicine. In this study, BD simulations of a wild type and mutants of BPTI using the program brownian were performed, and the results were compared with experimentally observed protein stabilities to investigate whether brownian can reproduce experimental results of mutants and evaluate its usefulness for simulations of mutants.
MATERIALS AND METHODS

Brownian particles follow the Langevin equation:
where m and v are the mass and velocity of the particle, respectively, and t, F, z, and F B are the time, interaction force, coefficient of friction, and random force, respectively. By Stokes' law, z is defined as follows:
where h is the viscosity of the solvent, and a is the radius of the particle. Since time is discretized and differential equations are approximated as difference equations in BD, the program brownian calculates the locations and velocities of Brownian particles using the equation derived by Ermak and Buckholz 
(
Vol. where r is the location of the particle, h is the time step, r B is the random difference in the location, and v B is a random difference in the velocity.
In this study, BD simulations of a wild type and mutants of BPTI were performed. The mutants used for BD are shown in Table 1 , which also describes their structural stabilities. 9, 10) In this table, mutants with melting points higher than 300 K are defined as stable. The 3D structure of BPTI was obtained from the Research Collaboratory for Structural Bioinformatics (RCSB) Protein Data Bank (PDB ID: 6 pti).
15) The construction of 3D structures of mutants was performed from the wild type by deleting side chain atoms. Hydrogen atoms of BPTI were added by the LEaP module of AMBER9.
For the simulations, preparatory calculations were performed by MD, and the structures obtained from the MD were used for production simulations. In order to evaluate the results, 3D structures of a wild type and mutants of BPTI were extracted from the trajectory of the production BD. Changes in the structures were observed and stabilities of these structures were investigated. For comparison, production simulations of BPTI were performed by both BD and MD. Not only the 3D structures from the trajectories but also computational times were compared between BD and MD.
In the preparatory calculations, temperature-increase simulations were performed from 0 to 300 K. The MD simulations were performed using the generalized Born (GB) implicit solvent model developed by Hawkins et al. 16) No cutoff was used, and 30-ps MD simulations with a 0.5-fs time step were performed. In the production BD, the dielectric constant and viscosity of the solvent, i.e., water, were calculated automatically by brownian. For the calculation of the dielectric constant, the approximate expression in the ref. 17 was used. The viscosity was obtained by the approximation formula derived from the data in the ref. 18 :
where t is the temperature in °C of the solvent. A cutoff length of 18.0 Å was used. In the production MD, the implicit solvent model with no cutoff was adopted, same as the preparatory MD. For both production simulations, BD and MD, 1-ns simulations with 1-fs time step were performed. The system temperatures were set as 300 K. The AMBER ff03 force field was used in all calculations. 19) The default setting of dielectric constant was used (1.0 for interior part of the protein, and 78.5 for exterior part and solvent). Thus, the dielectric constants of both BD and MD were determined in order to reproduce the water solvent. The MD simulations were performed using AMBER9 7) on a Celeron 3.33 GHz machine with 1 GB memory.
To compare computational times, simulations of a wild type were also performed using a Core2Duo E8500 3.16 GHz machine and Altix 4700 with Itanium 2 1.6 GHz CPUs. Altix 4700 is located at the Research Center for Computational Science, Okazaki Research Facilities, National Institutes of Natural Sciences. The memory installed was 2 GB in total (Core2Duo machine) and 11.5 GB per CPU core (Altix 4700). The number of CPU cores used was 1 or 2 for the Core2Duo machine, and 1, 2, 4, 8, 12, or 16 for Altix 4700. For parallelization, Open Message Passing Interface (Open MPI) was used for the Core2Duo machine, and Message Passing Toolkit was used for Altix 4700. In addition to the BPTIs, simulations of larger proteins were carried out in order to compare the computational times of BD and MD in detail. For these simulations, neuro-oncological ventral antigen 1 KH3 domain (NOVA-1, PDB ID: 1dt4, 73 residues), NK-lysin (PDB ID: 1nkl, 78 residues), FK506 binding protein (FKBP, PDB ID: 1d6o, 107 residues), Bombyx mori pheromone binding protein (PBP, PDB ID: 2fjy, 136 residues), and Golgi-associated, gamma adaptin ear-containing, ARF binding protein 2 VHS domain (GGA2, PDB ID: 1mhq, 143 residues) were used. The computational methods for them were same as BPTI simulations, and 16 CPU cores of Altix 4700 machine were used for calculations.
RESULTS AND DISCUSSION
In Fig. 1 , root mean square deviations (RMSDs) of the main chain during BD and MD simulations for wild type 1, instable mutant 2, and stable mutants 3, 4, and 5 are illustrated. The reference structure of the RMSD calculations is the initial structure, which is the structure before preparatory MD, for each BPTI. Comparing wild type 1 and mutant 2, in which all cysteine residues responsible for disulfide bonds were mutated, we see that although the RMSDs were smaller than 2.0 Å for wild type 1, those for mutant 2 were sometimes larger than 3.0 Å. The results indicate that the 3D structure of mutant 2 was broken, and BD simulations can reproduce experimentally observed instability of mutant 2. This suggests that molecular simulations can evaluate the structural stabilities of BPTI. Furthermore, the results of BD were qualitatively similar to those of MD in terms of the RMSDs of 1 and 2, suggesting that BD can be used as a substitute for MD. In terms of convergence speed, although the RMSDs of mutant 2 exceeded 3.0 Å at around 100-ps simulations for BD, MD required around 200-ps simulations. The results indicate that BD can change the structures of proteins faster than MD, and BD may be useful not only for molecular simulations but also for conformational searches or structure optimizations. Previously, we developed a conformational search method using high-temperature MD. 20) BD may also be used for this method.
The RMSDs of stable mutants 3, 4, and 5 by MD shown in Fig. 1 were low values, similar to those of wild type 1, and their RMSDs by BD were also smaller than 2.0 Å except for mutant 4. These results also indicate that structural stabilities of these mutants can be evaluated by molecular simulations. On the other hand, RMSDs of mutant 4 by BD were around 2.4 Å and slightly larger than wild type 1. This result suggests that the 3D structure of mutant 4 was broken by BD simulation. However, the experimentally observed melting C14A, C30A, F33A, C38A, C51A Instable point (t m ) of mutant 4 is 39.2°C (ϭ312.4 K), which is close to the simulation temperature (300 K). The low melting point may be the reason for the structural change in mutant 4 in BD simulations. In Fig. 2 , RMSDs for instable mutants 6 and 7 during BD and MD simulations are illustrated. For comparison, the results of wild type 1 and mutant 2 are repeated in this figure. As shown in the figure, RMSDs of both instable mutants calculated by BD were larger than those of wild type 1 by around 0.5 Å, and the 3D structures of these mutants were broken. Importantly, although the amino acid sequence of mutant 7 was different by only one residue from mutant 5, RMSDs of mutant 7 were similar to those of mutant 2, not mutant 5. These results indicate that effects on protein structures caused by a subtle difference in amino acid sequences can be reproduced by BD simulations. In contrast, RMSDs of mutant 7 by MD were similar to wild type 1, indicating that their 3D structures were not broken. The results were inconsistent with the experimental instability of mutant 7. Thus, BD seems to be more suitable for evaluating the structural stability of mutants than MD.
As shown in Figs. 1 and 2 , fluctuations of RMSD in BD were smaller than those in MD for all BPTIs. The viscosity terms in BD appear to prevent slight motions of the systems, and this was assumed to be the reason for the smaller fluctuations. On the other hand, despite the viscosity terms, BD can reproduce large structural changes in instable mutants 2, 6, and 7 better than MD. This suggests that important movements of proteins can be predicted by BD even if the viscosity term prevents slight motions. Thus, including the solvent effect using Brownian motion appears to be useful for biopolymer simulations.
Computational times for BD and MD simulations using a Celeron machine are shown in Fig. 3 . For all systems, BD was about three times (or more) faster than MD. The 1-ns BD simulations of BPTI constructed from 58 amino acid residues were performed in only about 14 h using a traditional Celeron machine. These results suggest that BD is a more accurate and faster method for mutant simulations than MD with implicit solvent.
In Table 2 , computational times of BD and MD simulations of wild type 1 using the Core2Duo machine and Altix 4700 are shown, and for comparison, those using the Celeron machine are also given. For single core calculations using both the Core2Duo and Altix 4700, BD is about four times faster than MD. Moreover, both machines can perform BD simulations faster than the Celeron machine. These results suggest that upgrading computers can improve computational times for brownian. In particular, the Core2Duo machine, which was the fastest of the three machines used in this study, could perform 1-ns simulations in only 4.5 h (single core). Thus, brownian can be used for large-scale simulations, or for molecular simulations of many biopolymers such as structural refinements of the results of virtual screening. By parallel computations, simulations were performed very fast because BPTI was small. Thus, when many CPU cores were used, the effect of non-parallelizable (sequential) parts such as file writing became relatively large, and parallel efficiency decreased. Thus, larger systems than BPTI are indispensable for parallel efficiency tests. However, even using BPTI, parallel efficiencies of brownian using the Core2Duo machine and Altix 4700 were 0.983 and 0.974, respectively, when two CPU cores were used, and those of AMBER were 0.982 and 0.996; therefore, the parallel efficiency of brownian was similar to that of AMBER, even though brownian's calculation speed is about four times faster. These results indicate that brownian is suitable for parallel computations. We intend to investigate the parallel efficiency of brownian further in a future study.
The computational times of the simulations of NOVA-1, NK-lysin, FKBP, PBP, and GGA2 by using 16 cores of Altix 4700 are shown in Table 3 . The calculated structures were not broken by the simulations for all proteins. In addition to these larger proteins, the computational times of BPTI were also included in the table for comparison. As shown in the table, computational times of BD were shorter than those of MD for all proteins. While the computational time of BD is about 1/2.5 of that of MD for BPTI, BD is three times (or more) as fast as MD for larger systems which have more than 100 residues. For example, the computational time of BD for GGA2 was shorter than 1/4 of that of MD. These results are consistent with those of BPTI by using Cerelon machine. They suggest that BD is much faster than MD, especially for larger systems under the parallel computing environment. Thus, brownian is expected to be useful for the simulations of much larger systems.
CONCLUSION
In this study, BD simulations of a wild type and mutants of BPTI were performed, and the BD program brownian for simulations of mutant proteins were evaluated. The results indicate that brownian can reproduce experimental stabilities of mutants, and requires much less computational time than MD using AMBER. Although this study was conducted for artificial mutants, brownian is also expected to be useful for natural mutants of proteins. The results suggest that brownian may be used to investigate the effects of genetic polymorphism, such as individual differences of drug metabolism. We already reported the usefulness of brownian for the computational study of induced fit between fatty-acid binding protein and palmitate, 6) and for the searches of ligand binding sites of proteins. 21) The results of this study and those previous studies indicate that brownian can be a useful tool for CADD. 
